 |
 |
|
| Startseite |
| Impressum |
| Datenschutz |
 |
| SPOT ON | |
Re-evaluation of HPV vaccination: is STIKO overcharged? | |
| NEW ON THE MARKET | |
QLAIRA: pill without chemistry? | |
| THERAPY FROM A CRITICAL VIEWPOINT | |
Treatment of neovascular age-related macular degeneration: bevacizumab (AVASTIN) or ranibizumab (LUCENTIS)? | |
| IN BRIEF | |
Baden-Württemberg medical journal: drug promotion = continuing medical education | |
| CURRENT ADR NETWORK REPORT | |
 |
Interaction of tramadol (TRAMAL, generics) and lamotrigine (LAMICTAL) |
| SIDE EFFECTS | |
Cataract surgery: floppy-iris syndrome due to tamsulosin (ALNA, generics) | |
| WARNINGS | |
Cancer due to insulin analogue glargine (LANTUS) | |
|
© arznei-telegramm 7/2009 | ||
 |  | |